Kuner
Arnold Kuner, St. Georgen DE
Patent application number | Description | Published |
---|---|---|
20080297084 | Control Circuit for an Electronically Commutated Motor - A control circuit for an electronically commutated motor ( | 12-04-2008 |
20080315807 | Method for Operating an Electronically Commutated Motor, and Motor for Carrying Out a Method Such as This - An electronically commutated motor (ECM | 12-25-2008 |
20100283419 | METHOD FOR OPERATION OF A TWO-PHASE ELECTRONICALLY COMMUTATED MOTOR AND MOTOR FOR CARRYING OUT SAID METHOD - A two-stranded electronically commutated DC motor has a permanent-magnet rotor ( | 11-11-2010 |
Jerry Kuner, Longmont, CO US
Patent application number | Description | Published |
---|---|---|
20100330039 | Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto - Disclosed are a fatty acid synthase (FAS) from | 12-30-2010 |
20140359900 | PRODUCTION OF DHA AND OTHER LC PUFAS IN PLANTS - The invention provides recombinant host organisms genetically modified with a polyunsaturated fatty acid (PUFA) synthase system and one or more accessory proteins that allow for and/or improve the production of PUFAs in the host organism. The present invention also relates to methods of making and using such organisms as well as products obtained from such organisms. | 12-04-2014 |
Jerry M. Kuner, Longmont, CO US
Patent application number | Description | Published |
---|---|---|
20100024050 | PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF - The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems isolated from or derived from non-bacterial organisms, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding biologically active domains of such a PUFA PKS system, to genetically modified organisms comprising PUFA PKS systems, to methods of making and using such systems for the production of bioactive molecules of interest, and to novel methods for identifying new bacterial and non-bacterial microorganisms having such a PUFA PKS system. | 01-28-2010 |
20110250342 | PUFA Polyketide Synthase Systems and Uses Thereof - Disclosed are the complete polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from | 10-13-2011 |
20130150599 | Production of DHA and Other LC-PUFAs in Plants - The invention provides recombinant host organisms (e.g., plants) genetically modified with a polyunsaturated fatty acid (PUFA) synthase system and one or more accessory proteins (e.g., PPTase and/or ACoAS) that allow for and/or improve the production of PUFAs in the host organism. The present invention also relates to methods of making and using such organisms (e.g., to obtain PUFAs) as well as products obtained from such organisms (e.g., oil and/or seed). | 06-13-2013 |
20140053299 | PUFA Polyketide Synthase Systems and Uses Thereof - Disclosed are the complete polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from | 02-20-2014 |
20140289904 | POLYUNSATURATED FATTY ACID PRODUCTION IN HETEROLOGOUS ORGANISMS USING PUFA POLYKETIDE SYNTHASE SYSTEMS - Disclosed are novel acyl-CoA synthetases and novel acyltransferases, nucleic acid molecules encoding the same, recombinant nucleic acid molecules and recombinant host cells comprising such nucleic acid molecules, genetically modified organisms (microorganisms and plants) comprising the same, and methods of making and using the same. Also disclosed are genetically modified organisms (e.g., plants, microorganisms) that have been genetically modified to express a PKS-like system for the production of PUFAs (a PUFA PKS system or PUFA synthase), wherein the organisms have been modified to express an acyl-CoA synthetase, to express an acyl transferase, to delete or inactivate a fatty acid synthase (FAS) expressed by the organism, to reduce competition for malonyl CoA with the PUFA synthase or to increase the level of malonyl CoA in the organism, and in one aspect, to inhibit KASII or KASIII. Additional modifications, and methods to make and use such organisms, in addition to PUFAs and oils obtained from such organisms, are disclosed, alone with various products including such PUFAs and oils. | 09-25-2014 |
Martin Kuner, Donaueschingen DE
Patent application number | Description | Published |
---|---|---|
20140188262 | METHOD AND DEVICE FOR AUTOMATIC ADDRESSING AND RECOGNITION OF SPATIAL PROXIMITY RELATIONSHIPS IN MODULAR SYSTEMS FOR TRANSFERRING OBJECTS - A method for the recognition of spatial proximity relationships in a modular system having module assemblies, each module assembly having a transmitter and a receiver arranged so that the transmitter of a first module assembly corresponds to the receiver of a second module assembly, and each of the module assemblies having a network connection for connection via a communication network to other of the module assemblies, includes: automatically requesting and allocating a network address for each of the respective network connections via the communication network so as to enable an addressing of the module assemblies via the network; and determining spatial proximity relationships of the module assemblies by triggering and evaluating the transmitters and receivers using the communication network via the network connection. | 07-03-2014 |
Ruprecht Kuner, Ostfildern DE
Patent application number | Description | Published |
---|---|---|
20120264638 | CIRCULATING miRNAs AS NON-INVASIVE MARKERS FOR DIAGNOSIS AND STAGING IN PROSTATE CANCER - The present invention relates to a method for staging prostate cancer in a subject suffering from prostate cancer, said method comprises (a) determining the amount of at least one miRNA selected from the group consisting of miRNA-375, miRNA-141, miRNA-200b, miRNA-516a-3p and miRNA9*, or the amount of a precursor molecule in a sample from said patient and (b) comparing the, thus, determined amount with a reference amount. Moreover, the present invention is concerned with a method for identifying a subject susceptible to prostate cancer therapy and to a method for diagnosing prostate cancer. Further envisaged by the present invention are a kit and a device adapted to carry out the method of the present invention. | 10-18-2012 |